Tweet
Developed by the Finlay Vaccine Institute, the drug, named SOBERANA 01, will be applied in two doses injected intramuscularly.
by OnCuba Staff
August 19, 2020
Cuba will begin clinical trials of its own vaccine against the SARS-CoV-2coronavirus next week, which will last until early 2021, the Cuban Public Registry of Clinical Trials reported this Tuesday.
Developed by the Finlay Vaccine Institute, the drug, named SOBERANA 01, will be applied in two doses injected intramuscularly, according to the report published yesterday, which did not specify more details about the nature of the vaccine.
The clinical trials, which will involve 676 people between the ages of 19 and 80, will be divided into two stages, the first of which will begin next Monday 24.
The Finlay center has set the completion of the study for January 11, 2021, and the results would be available on February 1 to be published on the 15th of the same month.
... Even so, the number of new daily cases remains in double digits, the total number of positive cases amounts to 3,408 and the deceased remain at 88 after fourteen days without deaths, low figures compared to the average of the region’s countries.
by OnCuba Staff
August 19, 2020
Cuba will begin clinical trials of its own vaccine against the SARS-CoV-2coronavirus next week, which will last until early 2021, the Cuban Public Registry of Clinical Trials reported this Tuesday.
Developed by the Finlay Vaccine Institute, the drug, named SOBERANA 01, will be applied in two doses injected intramuscularly, according to the report published yesterday, which did not specify more details about the nature of the vaccine.
The clinical trials, which will involve 676 people between the ages of 19 and 80, will be divided into two stages, the first of which will begin next Monday 24.
The Finlay center has set the completion of the study for January 11, 2021, and the results would be available on February 1 to be published on the 15th of the same month.
... Even so, the number of new daily cases remains in double digits, the total number of positive cases amounts to 3,408 and the deceased remain at 88 after fourteen days without deaths, low figures compared to the average of the region’s countries.
